JSE LIMITED - Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust

Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust

JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN Code: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
("JSE")


DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY
SECRETARY AND THE JSE LTIS 2018 TRUST

The JSE LTIS 2018 Trust ("Trust") has acquired 255 010 JSE ordinary shares
in the open market on behalf of executive directors, prescribed officers,
and the Company Secretary (“LTIS 2018 participants”) to fulfil share awards
granted in March 2022 to these LTIS 2018 participants under the JSE’s Long-
Term Incentive Scheme ("LTIS 2018").

These ordinary shares are held in trust and are restricted until all vesting
criteria are fulfilled whereupon the shares vest in the hands of LTIS 2018
participants. To the extent that the vesting criteria are not fulfilled
the share awards are forfeited.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively "the vesting criteria").

These JSE ordinary shares were acquired on-market, with prior clearance,
at a volume-weighted average price (“VWAP”) of R114.3936 per ordinary share.
The total transaction value amounted to R29 171 511. The daily high, low
and volume-weighted average price for the various transactions effected by
the Trust were –


  Dates in 2022
       that JSE                   Daily VWAP of
       ordinary   Number of JSE      JSE shares   Daily highest   Daily lowest
    shares were        ordinary        acquired      price paid     price paid
       acquired          shares      (cents per      (cents per     (cents per
                       acquired          share)          share)         share)

        7 March          15 000        11221.15           11261          11200
        8 March         107 000        11299.53           11410          11166
        9 March         133 010        11576.45           11606          11404

The requisite approvals have been granted by shareholders at the JSE’s
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these shares.


ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS
AND THE COMPANY SECRETARY

Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, the prescribed officers and the
Company Secretary have on 7 March 2022 accepted grants of restricted JSE
ordinary shares, as reflected below.

  Executive      Role            Total number    Total Rand value    Nature of
                                 of restricted   of restricted JSE   interest
                                 JSE ordinary    ordinary shares
                                 shares          awarded and
                                 awarded and     accepted
                                 accepted
  L Fourie       Group CEO &     92 530          10 584 839          Direct
                 Executive                                           beneficial
                 Director
  A Greenwood    Prescribed      29 900          3 420 369           Direct
                 Officer                                             beneficial
  V Lee          Prescribed      22 500          2 573 856           Direct
                 Officer                                             beneficial
  I Monale       Prescribed      26 130          2 989 105           Direct
                 Officer                                             beneficial
  P Ntoagae      Prescribed      16 750          1 916 093           Direct
                 Officer                                             beneficial
  M Randall      Prescribed      25 420          2 907 885           Direct
                 Officer                                             beneficial
  V Reddy        Prescribed      28 620          3 273 944           Direct
                 Officer                                             beneficial
  GA Brookes     Group Company   13 160          1 505 420           Direct
                 Secretary                                           beneficial


The restricted shares will vest in two tranches, one-half on 1 March 2025
and the remaining half on 1 March 2026, subject to the vesting criteria as
set out above being met.

The individual allocations (grant and acceptance) were approved by the JSE’s
Group Remuneration Committee and clearance to deal was granted by the
Chairman of the Board.

Sandton
11 March 2022

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 11-03-2022 07:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.